• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为致心律失常性右室心肌病导管消融终点的孤立延迟成分的变化:长期成功的预测指标。

Changes in the isolated delayed component as an endpoint of catheter ablation in arrhythmogenic right ventricular cardiomyopathy: predictor for long-term success.

作者信息

Nogami Akihiko, Sugiyasu Aiko, Tada Hiroshi, Kurosaki Kenji, Sakamaki Mihoko, Kowase Shinya, Oginosawa Yasushi, Kubota Shoichi, Usui Tatsuya, Naito Shigeto

机构信息

Division of Cardiology, Yokohama Rosai Hospital, Yokohama, Japan.

出版信息

J Cardiovasc Electrophysiol. 2008 Jul;19(7):681-8. doi: 10.1111/j.1540-8167.2008.01104.x. Epub 2008 Feb 13.

DOI:10.1111/j.1540-8167.2008.01104.x
PMID:18284499
Abstract

INTRODUCTION

Although successful ablation of ventricular tachycardia (VT) is feasible in arrhythmogenic right ventricular cardiomyopathy (ARVC), long-term recurrence is common. The aim of this study was to assess the usefulness of a change in the isolated delayed component (IDC) as an endpoint of the catheter ablation in ARVC.

METHODS AND RESULTS

Eighteen patients (48 +/- 11 years) with ARVC were studied. Detailed endocardial mapping of the right ventricle (RV) was performed during sinus rhythm. IDCs were recorded in 16 patients and the latest IDCs were related to the VT circuit. Catheter ablation was carried out in the areas with the IDCs. At the end of the session, the IDC was electrically dissociated in one, disappeared in five, exhibited second-degree block in one, was significantly delayed (>or=50 ms) in three, and remained unchanged in six. The change in the IDC was correlated with the change in the type II/III late potentials in the signal-averaged electrocardiography (ECG) and the inducibility of the clinical VT after the ablation. During a follow-up of 61 +/- 38 months, VT recurred in six. The patients with a changed IDC had a significantly lower VT recurrence than those with no IDC or an unchanged IDC (P < 0.02).

CONCLUSION

In patients with ARVC, (1) the IDCs during sinus rhythm are related to the clinical VT and can be a target for the ablation, (2) a change in the IDC can be used as an endpoint, and (3) qualitative analyses of the serial signal-averaged ECGs may be useful for the long-term follow-up.

摘要

引言

虽然在致心律失常性右室心肌病(ARVC)中成功消融室性心动过速(VT)是可行的,但长期复发很常见。本研究的目的是评估孤立延迟成分(IDC)的变化作为ARVC导管消融终点的有效性。

方法与结果

对18例(48±11岁)ARVC患者进行了研究。在窦性心律期间对右心室(RV)进行了详细的心内膜标测。16例患者记录到了IDC,且最晚的IDC与VT环路相关。在有IDC的区域进行了导管消融。在手术结束时,1例患者的IDC电分离,5例消失,1例出现二度阻滞,3例显著延迟(≥50毫秒),6例保持不变。IDC的变化与信号平均心电图(ECG)中II/III型晚电位的变化以及消融后临床VT的诱发性相关。在61±38个月的随访期间,6例患者VT复发。IDC发生变化的患者VT复发率显著低于IDC无变化或未改变的患者(P<0.02)。

结论

在ARVC患者中,(1)窦性心律期间的IDC与临床VT相关,可作为消融靶点;(2)IDC的变化可作为消融终点;(3)对系列信号平均ECG进行定性分析可能有助于长期随访。

相似文献

1
Changes in the isolated delayed component as an endpoint of catheter ablation in arrhythmogenic right ventricular cardiomyopathy: predictor for long-term success.作为致心律失常性右室心肌病导管消融终点的孤立延迟成分的变化:长期成功的预测指标。
J Cardiovasc Electrophysiol. 2008 Jul;19(7):681-8. doi: 10.1111/j.1540-8167.2008.01104.x. Epub 2008 Feb 13.
2
An unmappable ventricular tachycardia in the arrhythmogenic right ventricular cardiomyopathy: elucidation of critical isolated delayed components with high-resolution electroanatomical mapping.致心律失常性右室心肌病中无法标测的室性心动过速:采用高分辨率电解剖标测技术阐明关键的孤立延迟成分。
Europace. 2010 Feb;12(2):279-81. doi: 10.1093/europace/eup374. Epub 2009 Nov 27.
3
Left posterior fascicular block: a new endpoint of ablation for verapamil-sensitive idiopathic ventricular tachycardia.左后分支阻滞:维拉帕米敏感性特发性室性心动过速消融的新终点
Chin Med J (Engl). 2006 Mar 5;119(5):367-72.
4
Patients with scar-related right ventricular tachycardia: determinants of long-term outcome.瘢痕相关右室性心动过速患者:长期预后的决定因素。
J Cardiovasc Electrophysiol. 2009 Oct;20(10):1119-27. doi: 10.1111/j.1540-8167.2009.01516.x. Epub 2009 Jun 26.
5
Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.致心律失常性右室心肌病/发育不良患者行室性心动过速心外膜消融的心外膜基质与预后
Circulation. 2009 Aug 4;120(5):366-75. doi: 10.1161/CIRCULATIONAHA.108.834903. Epub 2009 Jul 20.
6
Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia.致心律失常性右室发育不良中基于基质的室性心动过速标测与消融的短期和长期疗效
Circulation. 2005 Jun 21;111(24):3209-16. doi: 10.1161/CIRCULATIONAHA.104.510503. Epub 2005 Jun 13.
7
Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation.在冠心病合并室性心动过速患者中使用CARTO进行基质标测与心动过速标测:对导管消融结果的影响
Europace. 2006 Nov;8(11):968-76. doi: 10.1093/europace/eul109.
8
Tachycardia-induced right ventricular cardiomyopathy: epicardial radiofrequency ablation of an unusual and unexpected ventricular tachycardia.心动过速性致右室心肌病:经心外膜射频消融治疗一种罕见且意想不到的室性心动过速
J Cardiovasc Electrophysiol. 2009 Jul;20(7):813-7. doi: 10.1111/j.1540-8167.2008.01402.x. Epub 2009 Jan 16.
9
Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy.右心室心肌病背景下室性心动过速导管消融治疗的电解剖基质与结果
Circulation. 2004 Oct 19;110(16):2293-8. doi: 10.1161/01.CIR.0000145154.02436.90. Epub 2004 Oct 11.
10
The morphology changes in limb leads after ablation of verapamil-sensitive idiopathic left ventricular tachycardia and their correlation with recurrence.维拉帕米敏感性特发性左心室心动过速消融术后肢体导联的形态学变化及其与复发的相关性。
J Cardiovasc Electrophysiol. 2008 Mar;19(3):238-41. doi: 10.1111/j.1540-8167.2007.01023.x. Epub 2007 Nov 21.

引用本文的文献

1
Catheter Ablation in Arrhythmic Cardiac Diseases: Endocardial and Epicardial Ablation.心律失常性心脏病的导管消融:心内膜和心外膜消融
Rev Cardiovasc Med. 2022 Sep 19;23(9):324. doi: 10.31083/j.rcm2309324. eCollection 2022 Sep.
2
Ventricular Tachycardia Catheter Ablation: Retrospective Analysis and Prospective Outlooks-A Comprehensive Review.室性心动过速导管消融术:回顾性分析与前瞻性展望——全面综述
Biomedicines. 2024 Jan 24;12(2):266. doi: 10.3390/biomedicines12020266.
3
Substrate-based approaches in ventricular tachycardia ablation.
基于基质的室性心动过速消融方法。
Indian Pacing Electrophysiol J. 2022 Nov-Dec;22(6):273-285. doi: 10.1016/j.ipej.2022.08.002. Epub 2022 Aug 23.
4
JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias.《日本循环学会/日本心律学会2019年心律失常非药物治疗指南》
J Arrhythm. 2021 Jun 2;37(4):709-870. doi: 10.1002/joa3.12491. eCollection 2021 Aug.
5
Epsilon wave disappearance by catheter ablation for ventricular arrhythmia from the left ventricular outflow tract.经导管消融治疗左心室流出道室性心律失常致ε波消失
HeartRhythm Case Rep. 2021 Mar 12;7(5):343-346. doi: 10.1016/j.hrcr.2021.02.012. eCollection 2021 May.
6
Ablation strategies for arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis.致心律失常性右室心肌病的消融策略:一项系统评价与荟萃分析
J Geriatr Cardiol. 2020 Nov 28;17(11):694-703. doi: 10.11909/j.issn.1671-5411.2020.11.001.
7
Catheter Ablation of Scar-mediated Ventricular Tachycardia: Are Substrate-based Approaches Replacing Mapping?瘢痕介导的室性心动过速的导管消融:基于基质的方法是否正在取代标测?
J Innov Card Rhythm Manag. 2019 Jun 15;10(6):3707-3715. doi: 10.19102/icrm.2019.100603. eCollection 2019 Jun.
8
Substrate Mapping and Ablation for Ventricular Tachycardia in Patients with Structural Heart Disease: How to Identify Ventricular Tachycardia Substrate.结构性心脏病患者室性心动过速的基质标测与消融:如何识别室性心动过速基质
J Innov Card Rhythm Manag. 2019 Mar 15;10(3):3565-3580. doi: 10.19102/icrm.2019.100302. eCollection 2019 Mar.
9
2019 APHRS expert consensus statement on three-dimensional mapping systems for tachycardia developed in collaboration with HRS, EHRA, and LAHRS.2019年亚太心脏节律学会与美国心律学会、欧洲心律协会及拉丁美洲心律学会合作制定的关于心动过速三维标测系统的专家共识声明。
J Arrhythm. 2020 Mar 9;36(2):215-270. doi: 10.1002/joa3.12308. eCollection 2020 Apr.
10
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.2019 年 HRS/EHRA/APHRS/LAHRS 专家共识声明:导管消融治疗室性心律失常。
J Interv Card Electrophysiol. 2020 Oct;59(1):145-298. doi: 10.1007/s10840-019-00663-3.